Visium Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Visium Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-123,492	Closed	-$1.83M	–	914
2015 Q3	$1.83M	Sell	123,492 -147,508	-54%	-$3.46M	0.03%	452
2015 Q2	$5.93M	Buy	271,000 +128	+0%	+$2.58K	0.08%	256
2015 Q1	$6.1M	Sell	270,872 -79,128	-23%	-$1.83M	0.09%	221
2014 Q4	$7.07M	Sell	350,000 -146,000	-29%	-$2.65M	0.1%	181
2014 Q3	$9.06M	Sell	496,000 -4,000	-0.8%	-$57.9K	0.13%	157
2014 Q2	$6.74M	Buy	500,000 +213,000	+74%	+$2.9M	0.1%	183
2014 Q1	$4.72M	Buy	+287,000	New	+$4.96M	0.08%	243

Other funds holding FLXN

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Visium Asset Management's FLXN Position: Q4 2015 in Review

Visium Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2015, closing a stake of 123,492 shares — an estimated $1.83M sold.

Visium Asset Management first reported a position in FLXN in Q1 2014 and held it in 7 quarters. The position peaked at $9.06M in Q3 2014. 64 funds tracked by Wall St. Rank hold FLXN as of Q4 2015.

Visium Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 123,492 Flexion Therapeutics, Inc. shares in Q4 2015, an estimated $1.83M.
Visium Asset Management first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Visium Asset Management's Flexion Therapeutics, Inc. position peaked at $9.06M in Q3 2014.
64 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.